Pancreatic Extracts

DBCAT000191Pharmacologic class

Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency. A DrugBank category of 1 drug. 1 of them is approved.

Also known as: Extracts, Pancreatic
Drugs: Pancrelipase

What you can answer from here — as of August 24, 2016

1DrugEach linked to its full drug card

Listed above

3Drug targetsEvery drug–target pair in the class, with bond type

217Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Pancreatic Extracts share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account